D

Dr. Veronica Gambillara Fonck

Partner
๐Ÿ’ผ Partner at Pureos Bioventures โ†’
About

Veronica joined the Pureos Bioventures team as a Partner in 2022. She has been a founder CEO of GlycoEra, a Zurich-based company with a glycoengineering platform for novel antibodies in autoimmune diseases, oncology and neurology. She was also a co-founder and the CEO of LimmaTech Biologics, a spin-off of GlycoVaxyn to service GSK. Before that, Veronica was in the executive team of GlycoVaxyn developing innovative vaccines for infectious diseases. She was instrumental in the acquisition of the company by GSK in 2015. Veronica is a bioengineer with a PhD in life science from the EPFL Lausanne.

Focus Areas

BioTech

Location

๐Ÿ“ Based in Zurich

Verified Contact & Outreach Agent

Direct Professional Email Pattern

[email protected] | [email protected]

AI Outreach Agent Pitch Writer

Compose an personalized, high-converting outreach message targeting their exact investment interest...

Unlock Direct Partner Outreach

View verified contact information and use our active Outreach Composer agent to draft custom intro pitches in seconds.

Connect via GRID to Outreach

100% free account ยท Get started in 1-click